InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (26 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
26
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Anders Jack, Autre. Director active across 1 company, notably Revolution Medicines, Inc.. In total, 41 filings have been published. Split: 0 buy · 26 sells. Total volume traded: €1.6m. History available since 17 June 2021. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Anders Jack
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
20,000 sharesCommon StockSEC:0001610717-26-000296:0
4,553 sharesCommon StockSEC:0001610717-26-000296:1
9,496 sharesCommon StockSEC:0001610717-26-000296:2
5,651 sharesCommon StockSEC:0001610717-26-000296:3
300 sharesCommon StockSEC:0001610717-26-000296:4
2,722 sharesCommon StockSEC:0001610717-26-000244:0
2,753 shares@ US$99.480416.3% of flowCommon StockSEC:0001610717-26-000128:0
20,200 shares0Common StockSEC:0001610717-26-000079:0
10,000 shares@ US$42.4515.4% of flowCommon StockSEC:0001610717-26-000012:0
3,104 shares@ US$77.090410.2% of flowCommon StockSEC:0001610717-25-000420:0
5,418 shares@ US$17.004.5% of flowCommon StockSEC:0001610717-25-000404:0
10,000 shares@ US$17.008.6% of flowCommon StockSEC:0001610717-25-000377:0
2,320 shares@ US$45.82495.7% of flowCommon StockSEC:0001610717-25-000346:0
2,814 shares@ US$2.680.4% of flowCommon StockSEC:0001610717-25-000326:0
2,170 shares@ US$39.836.1% of flowCommon StockSEC:0001610717-25-000239:0
1,864 shares@ US$39.04035.7% of flowCommon StockSEC:0001610717-25-000079:0
20,400 shares0Common StockSEC:0001610717-25-000055:0
2,635 shares@ US$45.40389.8% of flowCommon StockSEC:0001610717-24-000543:0
10,000 shares@ US$50.297939.5% of flowCommon StockSEC:0001610717-24-000507:1
10,000 shares@ US$2.682.1% of flowCommon StockSEC:0001610717-24-000507:0
2,244 shares@ US$44.18537.7% of flowCommon StockSEC:0001610717-24-000489:0
1,893 shares@ US$37.38765.7% of flowCommon StockSEC:0001610717-24-000351:0
10,000 shares@ US$2.682.1% of flowCommon StockSEC:0001610717-24-000229:0
1,261 shares@ US$31.58323.1% of flowCommon StockSEC:0001610717-24-000170:0
26,400 shares0Common StockSEC:0001610717-24-000130:0
25 of 41 declarations
About Anders Jack
Anders Jack is a declarant, identified in the recent filings as Chief Financial Officer at Revolution Medicines, Inc. He has 41 filings in total, and across the recent sampled filings covering the period from 2021-06-22 to 2026-06-26, the declared sell amount is EUR 1609295 and the stated transaction nature is Cession.
